Finally, we validated Pax5 expression in tissue microarrays (TMAs) derived from prostate cancer patient derived xenografts (PDX) (LuCaP series) and from metastatic CRPC (mCRPC) tissues obtained from Prostate Cancer Biorepository Network (PCBN). The gene discussed is PAX5; the disease is Familial prostate cancer.